Brief: Remus Pharmaceuticals Incorporates Subsidiary For Clinical Trial Material Management
20/06/2025 08:33
June 20 (Reuters) - Remus Pharmaceuticals Ltd REMP.NS: INCORPORATES SUBSIDIARY FOR CLINICAL TRIAL MATERIAL MANAGEMENT Source text: ID:nNSEbjVg2k Further company coverage: REMP.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Remus Pharmaceuticals
See all newsBrief: Remus Pharmaceuticals Re-Appoints Arpit Shah As MD
Brief: Remus Pharmaceuticals Incorporates Subsidiary For Clinical Trial Material Management
Brief: Remus Pharmaceuticals Acquiring Membership Interest Of 56.67% In Espee Global Holdings
Brief: Remus Pharmaceuticals To Sell Entire Stake In Unit Ratnatris Pharmaceuticals Via Shares Swap
Brief: Remus Pharmaceuticals To Make Strategic Investment In Espee Biopharma & Finechem LLC